Cassava Sciences Inc (SAVA)
26.48
-5.70
(-17.71%)
USD |
NASDAQ |
Nov 22, 16:00
26.62
+0.14
(+0.53%)
After-Hours: 20:00
Cassava Sciences Market Cap: 1.274B for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 22, 2024 | 1.274B |
| November 21, 2024 | 1.548B |
| November 20, 2024 | 1.253B |
| November 19, 2024 | 1.347B |
| November 18, 2024 | 1.345B |
| November 15, 2024 | 1.295B |
| November 14, 2024 | 1.258B |
| November 13, 2024 | 1.211B |
| November 12, 2024 | 1.269B |
| November 11, 2024 | 1.302B |
| November 08, 2024 | 1.297B |
| November 07, 2024 | 1.219B |
| November 06, 2024 | 1.278B |
| November 05, 2024 | 1.151B |
| November 04, 2024 | 1.243B |
| November 01, 2024 | 1.257B |
| October 31, 2024 | 1.238B |
| October 30, 2024 | 1.247B |
| October 29, 2024 | 1.272B |
| October 28, 2024 | 1.282B |
| October 25, 2024 | 1.274B |
| October 24, 2024 | 1.309B |
| October 23, 2024 | 1.343B |
| October 22, 2024 | 1.364B |
| October 21, 2024 | 1.386B |
| Date | Value |
|---|---|
| October 18, 2024 | 1.391B |
| October 17, 2024 | 1.419B |
| October 16, 2024 | 1.422B |
| October 15, 2024 | 1.356B |
| October 14, 2024 | 1.319B |
| October 11, 2024 | 1.238B |
| October 10, 2024 | 1.193B |
| October 09, 2024 | 1.199B |
| October 08, 2024 | 1.250B |
| October 07, 2024 | 1.219B |
| October 04, 2024 | 1.299B |
| October 03, 2024 | 1.293B |
| October 02, 2024 | 1.292B |
| October 01, 2024 | 1.316B |
| September 30, 2024 | 1.412B |
| September 27, 2024 | 1.367B |
| September 26, 2024 | 1.529B |
| September 25, 2024 | 1.462B |
| September 24, 2024 | 1.419B |
| September 23, 2024 | 1.296B |
| September 20, 2024 | 1.429B |
| September 19, 2024 | 1.457B |
| September 18, 2024 | 1.455B |
| September 17, 2024 | 1.502B |
| September 16, 2024 | 1.360B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
24.28M
Minimum
Nov 25 2019
5.414B
Maximum
Jul 28 2021
1.137B
Average
1.022B
Median
Market Cap Benchmarks
| Bristol-Myers Squibb Co | 119.40B |
| Seelos Therapeutics Inc | 0.1308M |
| EyePoint Pharmaceuticals Inc | 610.85M |
| PTC Therapeutics Inc | 3.334B |
| Adverum Biotechnologies Inc | 125.65M |
Market Cap Related Metrics
| PS Ratio | 29.06 |
| Price to Book Value | 7.645 |
| Price | 26.48 |
| Earnings Yield | -5.21% |
| Operating PE Ratio | 38.09 |
| Normalized PE Ratio | 5.563 |